Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in HKD, Millions.
The item "Other-Long-Term-Liabilities" stands at 195.95 Million Hong Kong Dollars as of 06/30/2025, the highest value since 09/30/2022.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 59.39 percent compared to the value the year prior.
The 1 year change in percent is 59.39.
The 3 year change in percent is -11.23.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Other Long Term Liabilities | 905,699,262,464.00 |
![]() | Johnson & Johnson - Other Long Term Liabilities | 486,508,953,600.00 |
![]() | AbbVie Inc - Other Long Term Liabilities | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Long Term Liabilities | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Long Term Liabilities | 280,205,508,085.11 |